Phacilitate Leaders World

Sponsors & Exhibitors

Longeveron

A Regenerative Medicine Company

Longeveron was founded to provide stem cell therapeutics for unmet medical needs.  The company’s lead product, Longeveron Mesenchymal Stem Cells (LMSCs), is currently being evaluated in several Phase 1 – 2b clinical trials under FDA oversight.   Indications being explored include Aging Frailty, hypoplastic left heart syndrome, the metabolic syndrome, and Alzheimer’s disease.  Longeveron is a private company, and recipient of 5 grant awards, including from the National Institutes of Health (National Institute of Aging), the Alzheimer’s Association, and the Maryland Stem Cell Research Fund (MSCRF)/TECDO.

Visit Website
View all Sponsors & Exhibitors
Loading
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK